Peripheral SpA: Dr. Antoni Chan and Dr. Nelly Ziade Dr. Chan ( @synovialjoints) interviews Dr. Ziade about abstract #1787 presented at the #ACR21 annual meeting. https://t.co/Sdd1HHKRib https://t.co/ynRocjviVu

Meta-analysis of PUFA supplementation in RA. Apparent benefits across most measures, albeit often small. Abstr#1682 #ACR21 @RheumNow https://t.co/1rGhpqvJvp

No benefit to using MTX in combination with ustekinumab in PsA. No difference in efficacy for arthritis, enthesitis, dactylitis, skin, QoL or function. Abstr#L12 #ACR21 @RheumNow https://t.co/iojKLqRb06

GLORIA study of adding prednisolone 5mg to DMARDs over 2 years for RA in those >65 years. Mean DAS 0.37 points lower, Sharp score 1.7 lower (are either of these clinically significant?). NNH 9.5. To me causing harm chasing statistical benefit Abstr#1678 #ACR21 @RheumNow #ACRBest https://t.co/KYk1II3J3w

Avacopan effects on renal disease in AAV presented in further detail. Greater recovery with avacopan, which was accentuated in those with worse renal disease or proteinuria at baseline. Abstr#L14 #ACR21 @RheumNow https://t.co/dfTmhhsNnX

Clinical and research pearl: SPACC vs LEEDs enthesitis scoring for your PsA patients by Dr. Ogdie. #ACR21 @RheumNow #RheumNow https://t.co/dDznwSicRQ

I don't know much about antifibrotics in RA-ILD, but these data emphasise that HRCT pattern matters My simple mind, for any disease: multiple subtypes with different trajectories➡️likely to be differing responses to Rx TRAIL1: pirfenidone in RA-ILD #ACR21 ABSTL10 @RheumNow https://t.co/v7HCO0ZBe1

#SARSCoV2 infections in vaccinated pts w/ #rheumaticdisease @rheum_covid @rheum_cat 👉🏼Most pts with breakthrough infections were on anti-metabolites or B-cell depleting therapies 👉🏼Encourage patients to get their #BoosterShot! Abs#L04 #ACR21 @RheumNow https://t.co/TAB4zrjPN1 https://t.co/z0gpsxN3xc

⬆HCQ blood levels significantly associated w/ ⬇ in mean SLEDAI, UPCR, SBP & platelet cts 🔷Assoc'n strongest in HCQ conc'n in range 0-1000ng/mL A possible HCQ blood level target to ⬇ 👁toxicity?🤔 @RheumNow #ACR21 abs1753 https://t.co/3jkDDakIcb

Comparative effects of abatacept in RA-ILD with UIP/NSIP. Appears equally effective in stabilising FVC, DLCO, and HRCT findings in both. Abstr#1683 #ACR21 @RheumNow https://t.co/l0Ia1D9c56

Abst1510 #ACR21 @RheumNow in animal study Stimulation w/ SIINFEKL peptide induces proliferation of resident memory CD8+ T cells in target joint resulting in increased numbers of B cells, Neutrophils, and CD4 cells within the joint space =localized inflammatory arthritis https://t.co/QlYT8OyGTt